At a Glance
Dosage
oral
| Level | ALD-52 | 1cP-MiPLA |
|---|---|---|
| Threshold | 30 µg | 50 µg |
| Light | 30–100 µg | 100–150 µg |
| Common | 100–175 µg | 150–200 µg |
| Strong | 175–325 µg | 200–250 µg |
| Heavy | 325 µg | 300 µg |
Duration
oral
ALD-52
oral
Total: 8 hrs – 14 hrsPeak
Offset
Afterglow
Onset20 min – 40 min
Come Up1 hrs – 2 hrs
Peak3 hrs – 5 hrs
Offset
Effects
Safety
Interaction: ALD-52 + 1cP-MiPLA
No direct interaction data available between these substances. This does not mean the combination is safe.
ALD-52 — Dangerous Interactions
No dangerous interactions recorded.
1cP-MiPLA — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between ALD-52 and 1cP-MiPLA?
ALD-52 is classified as a Psychedelic (Lysergamides) while 1cP-MiPLA is classified as a Psychedelic (Lysergamides). They share 55 effects in common, with 16 effects unique to ALD-52 and 15 unique to 1cP-MiPLA.
Is it safe to combine ALD-52 and 1cP-MiPLA?
There is no direct interaction data available for combining ALD-52 and 1cP-MiPLA. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, ALD-52 or 1cP-MiPLA?
At common doses via oral, ALD-52 is typically dosed at 100–175 µg while 1cP-MiPLA is dosed at 150–200 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.